Preserve tissue health with microvascular insights
Modulim (modulim.com) earns a Brand Analyzer score of 66 out of 100, placing it in the Developing tier among Healthcare brands, SaaS brands. Among 2305 Healthcare brands analyzed, Modulim ranks in the 37th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 100/100, Digital Presence 82/100, Visual Identity 90/100, Messaging Clarity 95/100, Trust Foundation 73/100, AI Discoverability 37/100, Brand Authority 11/100.
Modulim is a healthcare and SaaS company focused on lower limb tissue health. Its mission is to preserve tissue health by providing clinicians with actionable microvascular and data insights for the lower limb. The platform targets patients at risk for complications related to diabetes, kidney disease, and peripheral arterial disease, aiming to reduce hospitalizations, lower costs, improve outcomes, and increase patient satisfaction.
| Brand Name | Modulim |
|---|---|
| Domain | modulim.com |
| Industry | Healthcare, SaaS |
| Main Competitors | Invacare, Podimetrics, Tissue Analytics, Nuo Therapeutics, Swift Medical (72/100) |
Moz Domain Authority 31/100 vs category average 29 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Our mission is to preserve tissue health by empowering clinicians with actionable microvascular and data insights for the lower limb." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on Facebook, LinkedIn, Instagram, YouTube, GitHub; no detected presence on X (Twitter) - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Modulim scores 27/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Modulim has a weak AI-visibility profile at 27/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (50/100) and its weakest is visibility (17/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 31/100 and thin schema.org structured data.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Modulim's main competitors include Invacare, Podimetrics, Tissue Analytics, Nuo Therapeutics, Swift Medical (72/100). These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Modulim official site
Modulim and Swift Medical are competitors in Healthcare. Brand Analyzer scores Modulim at 66/100 and Swift Medical at 72/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Modulim official site
Popular alternatives to Modulim include Invacare, Podimetrics, Tissue Analytics, Nuo Therapeutics, Swift Medical (72/100). Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Modulim official site
Modulim has limited AI-search visibility, scoring 27/100 on Brand Analyzer's AI visibility composite (visibility 17, trust 22, recommendation 50). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Modulim official site
Modulim is a healthcare and SaaS company whose mission is to preserve tissue health by empowering clinicians with actionable microvascular and data insights for the lower limb. It positions itself as a leading provider of actionable insights for lower limb tissue health preservation, serving clinicians who manage patients at risk for complications from diabetes, kidney disease, and peripheral arterial disease.
Sources: Modulim official site
Modulim provides clinicians with microvascular and data insights focused on the lower limb. By delivering these insights, the company aims to reduce hospitalizations and complications, improve patient satisfaction, and lower the costs associated with managing lower limb risks stemming from conditions such as diabetes, kidney disease, and peripheral arterial disease. Its offerings span both healthcare services and a SaaS platform.
Sources: Modulim official site
Modulim scores 50/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Modulim official site
Based on the available facts, Modulim offers a healthcare and SaaS platform that delivers microvascular and data insights for the lower limb. These insights are designed to help clinicians manage lower limb risks associated with diabetes, kidney disease, and peripheral arterial disease, with goals of reducing hospitalizations, preventing complications, improving patient satisfaction, and lowering overall care costs. Specific product names or detailed feature lists are not provided in the known facts.
Sources: Modulim official site
Modulim's platform is used by clinicians who treat patients at risk for lower limb complications due to diabetes, kidney disease, and peripheral arterial disease. These are healthcare professionals seeking actionable microvascular and data insights to guide clinical decision-making, reduce hospitalizations, prevent complications, and improve patient outcomes in lower limb tissue health management.
Sources: Modulim official site
Modulim can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Modulim official site
Modulim is known for providing actionable microvascular and data insights for lower limb tissue health preservation. Its platform specifically addresses the clinical needs of patients at risk for lower limb complications due to diabetes, kidney disease, and peripheral arterial disease, positioning it as a specialized tool for clinicians seeking to improve patient outcomes and reduce care costs in this domain.
Sources: Modulim official site
Ranked closest to Modulim: Mobile Aspects (66/100), MedQuick (66/100), Momentm Technologies (66/100), My One Medical Source® (MOMS) (66/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Dassault Systèmes (95/100).